NEW YORK – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE: PFE) COVID-19
12 months ago
On Thursday, Gilead Sciences (NASDAQ: GILD) said it has appointed Sanofi’s (NASDAQ: SNY) Dietmar Berger as its chief medical officer,
1 year ago
SHANGHAI – Sanofi (NASDAQ: SNY) plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production
Sanofi (NASDAQ: SNY), the French drugmaker, plans to change its policy on how it gives discounts to certain U.S. hospitals
On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third
LONDON – Buyout fund CD&R’s keenly awaited 16 billion euro ($17.36 billion) deal to take control of Sanofi’s (NASDAQ: SNY)
PARIS – Sanofi (NASDAQ: SNY) agreed on terms to sell a controlling stake in its consumer health unit Opella to
PARIS – On Monday, Sanofi (NASDAQ: SNY), the French drugmaker, said it had entered exclusive talks to sell a 50%
PARIS – On Thursday, Sanofi (NASDAQ: SNY), the French drugmaker, said it was “surprised” by a renewed, higher offer for
PARIS – The French government needs guarantees from drugmaker Sanofi (NASDAQ: SNY) that production of its popular Doliprane painkiller will
Sanofi (NASDAQ: SNY) is closing in on a deal to sell its consumer health unit for about 15 billion euros
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
